(Total Views: 225)
Posted On: 03/16/2017 2:40:00 PM
Post# of 15624
What's happening now has happened with every other run if you look at the charts. You're right, once efficacy results are out I expect a massive run and then the same ole consolidation retrace. For now that's good since I need to add shares.
Once the Q's start showing revenue from commercialization, then at least for a while the price should stabilize. And that's only for the cream. The sublingual tablet could again throw the stock into the run->retrace mode until commercialization of that.
If the price could get to around $1.50 before results, that would be a good launching point.
Once the Q's start showing revenue from commercialization, then at least for a while the price should stabilize. And that's only for the cream. The sublingual tablet could again throw the stock into the run->retrace mode until commercialization of that.
If the price could get to around $1.50 before results, that would be a good launching point.
(1)
(0)
